Get started
Author

Sepideh Saadatmand

Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173 797 patients
2015 · Sepideh Saadatmand, Reini Bretveld, et al. · BMJ · 349
PDF
MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial
2019 · Sepideh Saadatmand, H Amarens Geuzinge, et al. · The Lancet Oncology · 183
PDF
Breast conserving therapy and mastectomy revisited: Breast cancer‐specific survival and the influence of prognostic factors in 129,692 patients
2017 · Mirelle Lagendijk, Marissa C. van Maaren, et al. · International Journal of Cancer · 165
PDF
Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis
2016 · Xuan-Anh Phi, Sepideh Saadatmand, et al. · British Journal of Cancer · 117
PDF
Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study ( MRISC )
2015 · Sepideh Saadatmand, Inge‐Marie Obdeijn, et al. · International Journal of Cancer · 96
PDF
Cost-Effectiveness of Screening Women With Familial Risk for Breast Cancer With Magnetic Resonance Imaging
2013 · Sepideh Saadatmand, Madeleine M. A. Tilanus-Linthorst, et al. · JNCI Journal of the National Cancer Institute · 65
Addition of interferon‐α to the p53‐SLP® vaccine results in increased production of interferon‐γ in vaccinated colorectal cancer patients: A phase I/II clinical trial
2012 · Eliane C.M. Zeestraten, Frank M. Speetjens, et al. · International Journal of Cancer · 63
PDF
Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk
2020 · H. Amarens Geuzinge, Inge-Marie Obdeijn, et al. · JAMA Oncology · 56
PDF
Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysis
2017 · Xuan-Anh Phi, Nehmat Houssami, et al. · European Journal of Cancer · 41
PDF
Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial
2012 · Sepideh Saadatmand, Emiel J T Rutgers, et al. · BMC Cancer · 19
PDF
Relevance and efficacy of breast cancer screening inBRCA1andBRCA2mutation carriers above 60 years: A national cohort study
2014 · Sepideh Saadatmand, Janet R. Vos, et al. · International Journal of Cancer · 17
MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancer
2018 · Mirelle Lagendijk, Sepideh Sadaatmand, et al. · Oncotarget · 15
PDF
[Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173,797 patients].
2016 · Sepideh Saadatmand, Reini Bretveld, et al. · PubMed · 6
Abstract GS4-07: Costs and effects in the first randomized trial comparing MRI breast cancer screening with mammography in women with a familial risk: FaMRIsc
2020 · Madeleine MA Tilanus-Linthorst, H Amarens Geuzinge, et al. · Cancer Research · 1
[Choices for women at risk of hereditary breast cancer].
2013 · Sepideh Saadatmand, Inge-Marie Obdeijn, et al. · PubMed · 1
Famrisc, a RCT comparing mammography with MRI in screening for familial risk
2020 · Amarens Geuzinge, Sepideh Saadatmand, et al. · European Journal of Surgical Oncology
Correction: MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancer
2018 · Mirelle Lagendijk, Sepideh Saadatmand, et al. · Oncotarget
PDF
Breast Cancer Screening in Women with Hereditary or Familial Risk
2015 · Sepideh Saadatmand · EUR Research Repository (Erasmus University Rotterdam)
Works count: 18
Citation count: 1,194
H-index: 12
I10-index: 12
Year
Topic
Type